News/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivLess than 1 min readCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. EuropeGerman stocksMergers and acquisitionsNorth AmericaReutersUK stocksUS stocksUnited Kingdom© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlShow moreLogin or create a forever free account to read this newsLet's go
